Attention-deficit/hyperactivity disorder (ADHD) is a complex neurodevelopmental disorder that affects both children and adults. It is characterized by symptoms such as inattention, hyperactivity, and impulsivity, which can significantly impact daily life and functioning. As awareness of ADHD continues to grow, so does the demand for effective treatment options. While behavioral therapies are often recommended, pharmacological interventions are also frequently utilized. Among these, Atomoxetine and Guanfacine have emerged as two popular non-stimulant medications. Atomoxetine, a selective norepinephrine reuptake inhibitor, is primarily used in the treatment of ADHD. It works by increasing the levels of norepinephrine in the brain, which helps improve attention and decrease impulsivity and hyperactivity. On the other hand,…